By proceeding, you agree to our Terms of Use and Privacy Policy.
Extensive expertise in pre-clinical models and IND-enabling drug discovery. • Scientist and strategic leader with experience of bringing early-stage discoveries into clinic.
Talks About #biotechnology #lifesciences
Preferred Locations #Northamerica
With 2023 on track to see further growth in the immuno-oncology field, the availability of tools that offers drug developers & researchers advantages that weren’t available to them even a few years ago is increasing rapidly.